Systemisk optagelse af atazanavir i doser, der medførte maternel toksicitet, var mindst lig med, eller en anelse større end den, der blev observeret hos mennesker, der fik 400 mg én gang dagligt.
Systemic exposure to atazanavir at doses that resulted in maternal toxicity was at least equal to or slightly greater than that observed in humans given 400 mg once daily.